Evaluating effect of teriflunomide on cortical atrophy in a subgroup analysis of patients defined by baseline MRI activity in the Phase 3 TOPIC study

被引：0
|
作者：
Zivadinov, R. [1 ]
Dwyer, M. G. [1 ]
Carl, E. [1 ]
Thangavelu, K. [2 ]
Cavalier, S. [2 ]
Bergsland, N. [1 ]
机构：
[1] Univ Buffalo, Buffalo, NY USA
[2] Sanofi Genzyme, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PR2092
引用
收藏
页码：580 / 580
页数：1
相关论文
共 50 条
  • [21] A Subgroup Analysis of Low Disease Activity and Remission from Phase 3 Study of Filgotinib in Patients with Inadequate Response to Biologic DMARDs
    Gottenberg, Jacques-Eric
    Buch, Maya
    Caporali, Roberto
    Wright, Grace
    Takeuchi, Tsutomu
    Kalunian, Kenneth
    Pechonkina, Alena
    Guo, Ying
    Rao, Shangbang
    Tan, YingMeei
    Besuyen, Robin
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [22] Treatment response to avacincaptad pegol by baseline patient characteristics: A prespecified subgroup analysis of the phase 3 GATHER2 study
    Danzig, Carl J.
    Kaiser, Peter
    Lally, David
    Jaffe, Glenn J.
    Khanani, Arshad M.
    Wykoff, Charles Clifton
    Heier, Jeffrey S.
    Tang, Justin
    Zhu, Liansheng
    Clark, Julie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] EFFICIENCY OF SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) INCREASES WITH SEVERITY OF HYPERKALAEMIA: SUBGROUP ANALYSIS OF PATIENTS STRATIFIED BY BASELINE POTASSIUMIN THE PHASE 3 HARMONIZE STUDY
    Mann, Johannes
    Rasmussen, Henrik
    Lavin, Philip
    Yang, Alex
    Spinowitz, Bruce
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [24] Effect on disability measures and msfc in patients with relapsing multiple sclerosis from the phase 3 ponesimod versus teriflunomide optimum study
    Fox, R.
    Kappos, L.
    Burcklen, M.
    Freedman, M.
    Havrdova, E.
    Hennessy, B.
    Hohlfeld, R.
    Lublin, F.
    Montalban, X.
    Pozzilli, C.
    Scherz, T.
    Linscheid, P.
    Ford, L.
    Pirozek-Lawniczek, M.
    Kracker, H.
    Sprenger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 216 - 217
  • [25] An interim analysis of monthly surveillance 3T MRI in MS patients switching from long term natalizumab to teriflunomide in a prospective study
    Edwards, K. R.
    Cohan, S.
    Thomas, J.
    O'Connor, J. T.
    Gervasi, T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 289 - 289
  • [26] Effect of Teriflunomide on substantial disability worsening in patients with relapsing forms of MS in a Pooled Analysis of the phase-3 TEMSO and TOWER studies
    Kappos, L.
    Miller, A.
    Poole, E.
    Chavin, J.
    Truffinet, P.
    Freedman, M. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 433 - 433
  • [27] Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study
    Wasat Mansoor
    Hendrik-Tobias Arkenau
    Maria Alsina
    Kohei Shitara
    Peter Thuss-Patience
    Sinead Cuffe
    Mikhail Dvorkin
    David Park
    Takayuki Ando
    Marc Van Den Eynde
    Giordano D. Beretta
    Alberto Zaniboni
    Toshihiko Doi
    Josep Tabernero
    David H. Ilson
    Lukas Makris
    Karim A. Benhadji
    Eric Van Cutsem
    Gastric Cancer, 2021, 24 : 970 - 977
  • [28] Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study
    Mansoor, Wasat
    Arkenau, Hendrik-Tobias
    Alsina, Maria
    Shitara, Kohei
    Thuss-Patience, Peter
    Cuffe, Sinead
    Dvorkin, Mikhail
    Park, David
    Ando, Takayuki
    Van den Eynde, Marc
    Beretta, Giordano D.
    Zaniboni, Alberto
    Doi, Toshihiko
    Tabernero, Josep
    Ilson, David H.
    Makris, Lukas
    Benhadji, Karim A.
    Van Cutsem, Eric
    GASTRIC CANCER, 2021, 24 (04) : 970 - 977
  • [29] A subgroup analysis of JUMP, a phase IIIb, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis in a Brazilian cohort
    Tavares, Renato
    Souza, Carmino Antonio De
    Paley, Carole
    Bouard, Catherine
    Tiwar, Ranjan
    Pasquini, Ricardo
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 46 - 53
  • [30] Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer
    Kiyota, Naomi
    Schlumberger, Martin
    Muro, Kei
    Ando, Yuichi
    Takahashi, Shunji
    Kawai, Yasukazu
    Wirth, Lori
    Robinson, Bruce
    Sherman, Steven
    Suzuki, Takuya
    Fujino, Katsuki
    Gupta, Anubha
    Hayato, Seiichi
    Tahara, Makoto
    CANCER SCIENCE, 2015, 106 (12) : 1714 - 1721
12345